Publications
5677 Results
- Journal / Conference
- Journal of Geriatric Oncology, Mar;13(2):258-264
- Year
- 2022
- Research Committee(s)
- Lymphoma
- PMID
- PMID34686472
- PMC
- PMC9879719
- Study Number(s)
- S1918
SWOG 1918: A phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed aggressive non-Hodgkin lymphomas – Aiming to improve therapy, outcomes, and validate a prospective frailty tool
- Journal / Conference
- Clinical Cancer Research Feb 15;28(4):611-617
- Year
- 2022
- Research Committee(s)
- Breast
- PMID
- PMID34844978
- PMC
- PMC9782801
- Study Number(s)
- S1222
A randomized trial of fulvestrant, everolimus and anastrozole in the front line treatment of advanced hormone receptor positive breast cancer, SWOG S1222
- Journal / Conference
- Endocrine-Related Cancer Jan 20;29(2):99-109. doi: 10.1530/ERC-21-0107
- Year
- 2022
- Research Committee(s)
- Cancer Control
- PMID
- PMID34889205
- PMC
- PMC8776589
- Study Number(s)
- SWOG-9217
Serum Markers, Obesity and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
- Journal / Conference
- Journal of the National Cancer Institute Mar 8;114(3):372-380; Jan 4;djab210. doi: 10.1093/jnci/djab210. Online ahead of print.
- Year
- 2022
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID34981117
- PMC
- PMC8902339
- Study Number(s)
- S1417CD
S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients
- Journal / Conference
- European Urology May;81(5):458-462
- Year
- 2022
- Research Committee(s)
- Cancer Control, Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
- PMID
- PMID35031163
- PMC
- PMC9018520
- Study Number(s)
- S0000, SWOG-9217
A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry
- Journal / Conference
- ASCO Gastrointestinal Cancer Symposium (Jan 20-22, 2022, San Francisco, CA), TIPS poster session
- Year
- 2022
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S1922
Randomized Phase II Selection Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma: SWOG S1922
- Journal / Conference
- ASCO Gastrointestinal Cancer Symposium (Jan 20-22, 2022, San Francisco, CA), TIPS poster session
- Year
- 2022
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S2104
Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide versus Observation in High-Risk Pancreatic Neuroendocrine Tumors: SWOG S2104
- Journal / Conference
- American Journal of Clinical Nutrition Jan 18;nqac013. doi: 10.1093/ajcn/nqac013. Online ahead of print.
- Year
- 2022
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID35040869
- Study Number(s)
- S0000C
Change in Plasma Alpha-Tocopherol Associations with Attenuated Pulmonary Function Decline and with CYP4F2 Missense Variation
- Journal / Conference
- Journal of Clinical Oncology May 10;40(14):1574-1582
- Year
- 2022
- Research Committee(s)
- Leukemia
- PMID
- PMID35157496
- PMC
- PMC9084435
- Study Number(s)
- S1318
SWOG 1318: A Phase 2 Trial of Blinatumomab Followed by POMP Maintenance in Older Patients with Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia
- Journal / Conference
- Journal of Clinical Oncology Mar 1;40(7):740-751; Jan 7;JCO2101784. doi: 10.1200/JCO.21.01784. Online ahead of print
- Year
- 2022
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID34995084
- PMC
- PMC8887946
- Study Number(s)
- C89803